Dr. Paulo has earned the 2006 Honourable Deeds and the 2007 Prize Quality of the Amélia da Silva Mello Foundation, the 2008 Honourable Deeds Bial Prize of Medicine, the 2009 Praise of the Ministry of Health, the 2009 Health Order of Merit of the Govern of Minas Gerais, the 2013 Health Medal of Merit of the Portuguese Health Ministry and a Recognition of the S. Tome and Prince Government (2013).
Besides all this, Dr. Paulo has attended 192 communications and conferences, produced 20 articles and participated in 12 books.
She is currently an Associated Professor at Cooperativa de Ensino Superior Politécnico Universitário (CESPU) and an Assistant Professor at Instituto de Ciências Biomédicas Abel Salazar, at Porto’s University. Teresa Temudo is a leading researcher of the Neuropediatric team at Porto’s Hospital Centre. Distinguished by numerous awards such as the 3rd place in the “CGC Genetics Professor Doctor Amândio Tavares” Prize, in 2010, with the article “Clinical and Genetic study of Rett’s Syndrome n Portugal” and the prize awarded by the DEFI in areas of Education, Training and Research, in 2009, with the article “Mutations in the MECP2 gene are not a major cause of Rett syndrome-like or related neurodevelopmental phenotype in male patients”.
Dr. Teresa Temudo is the author of numerous articles published at major Journals related to Medicine and investigation, such as Pubmed. Her work in areas related to Neurodevelopment are noteworthy, specially the researches on Rett syndrome’s.
Originally from Lisbon, Portugal, and trained as a mechanical engineer, he completed his PhD studies in Biomedical Engineering (with high distinction) in 2015, at the Technical University of Lisbon, Portugal. Between 2012 and 2014, he was a visiting research scholar at the University of Würzburg, Germany, and worked in a biomaterials company for the development and CE marking of tissue-engineered bone substitutes. He is currently working on generating 3D bone and cartilage tissue equivalents by applying 3D-bio-printing technologies, and simultaneously he is lecturing at first international Master’s degree in Biofabrication, Utrecht University, the leading institution in the field of Biofabrication.
Dr. Castilho has published his research in biofabrication and biomaterials high-ranking international journals and he is an active contributor to international scientific conferences in the field.
He is also a certified instructor by the International Directory of MBSR Teachers and Programs of the do Center for Mindfulness from the Medical School of the University of Massachussetts University (USA) and a member of the American Mindfulness Research Association.
Dr. Lopes completed his Master’s degree in Mindfulness-Based Approaches, at Bangor University (UK), in 2015. His thesis concerned “Mindfulness-Based Intervention in Cancer Recovery (MBICR) in a Portuguese Population”.
He was the instructor of several courses for health professionals, in 2012 and 2013, in Aveiro and Santa Maria da Feira, in which over 50 professionals (psychiatrists and other specialists, psychologists, nurses and occupational therapists) participated.
He completed his Neurology residency and worked as a clinical neurologist at the Hospital Egas Moniz (Lisbon), where he created and ran Multiple Sclerosis Clinics.
He started to work in the field of pharmaceutical industry, in 2008, at Roche Pharmaceuticals, directing the development of new therapies for neurological and psychiatric diseases.
He has published numerous papers in leading publications regarding new and emerging therapies for Multiple Sclerosis and received several honors and awards including a Fulbright Scholarship, Gulbenkian Foundation and Fundacion Salud 2000 research awards, and a European Charcot Foundation Young Investigator Award.
He is currently taking his residency in Anaesthesiology and is working at the Naval Medical Centre and at the Armed Forces Hospital. He is also an investigator at the Preventive Medicine Institute of Lisbon’s Medical School.
He has undertaken numerous humanitarian missions, namely the OBANGAME/SAHARAN Express (2014) and the FRONTEX – Operação Triton (2014). He has also taken part in rescue missions in Azores and given medical support on UAM Creoula.
Dr. Nelson has an astonishing path in the trauma field: he obtained Trauma Fellow from the Rambam Medical Centre, Israel; he is a former Emergency Doctor for INEM, a former Navy Medical Officer, and a former Field Hospital Medical Coordinator for the Portuguese Civil Protection.
His major areas of interest include wound ballistics, war surgery, mass casualty management, the quality of surgical care in austere environments, technology, and health care in armed conflicts.
His major fields of study are Pharmacology (research on the adrenergic and cardiovascular systems), Therapeutics (clinical trials) and Bioethics (especially medical ethics and experimentation ethics).
He was the Director of the Bioethics Institute of the Universidade Católica Portuguesa (UCP), a member of the National Ethics Council for the Life Sciences (CNECV), Director of the Pharmacology and Therapeutics Institute of the Faculty of Medicine in Porto (1988-1993), President of the Bioethics Research Centre of the UCP (1995-2000), visiting Professor at the Universities of Gand, Paris, Düsseldorf, Frankfurt, Kuwait, Valencia, and the President of the National Humanization Committee (MS) 1995-2000, a member and Chairman of the Working Party on the Protection of the Embryo and the Foetus – European Union (1998-2001), President of the Grünenthal Foundation (since 1999) and a member and President of various Ethics Committees (S. João Hospital, Hospital Centre at Conde de Ferreira, and S. João de Deus Hospitals, of the University of Porto).
Currently, he is an Advisor at the Bioethics Institute of the UCP.
She majored in 1974 from Chatham University, Pennsylvania, in Biology and Chemistry and received her medical degree in 1978 from the Tufts University School of Medicine in Boston, Massachusetts.
She completed her Anesthesiology residency at Harvard’s Beth Israel Hospital in Boston. Fellowships in Neurosurgical and Obstetrical Anesthesia followed.
She has been a military doctor, a private contractor/fee for service doctor/a hospital employee and a locums tenens physician. She was Chief of Anesthesiology at a hospital in Richland, Washington.
Dr. Charity’s talk titled “So you want to be a Medical Doctor? AWESOMESAUCE!” aims to motivate you to keep going no matter the obstacles. There is a worldwide shortage of physicians. We, the future doctors of the world, are needed today, more than ever.
Since then, Dr. Hughes combines a passion for critical thinking and decision-making with an interest in teaching undergraduate medical students. He believes it is not only possible, but essential, for doctors to learn to understand how they make decisions, so that the safety of patients is improved.
Teaching is one of the things Dr. Hughes is recognized for, as a Senior Fellow in Medical Education. He believes that teaching young minds before they have developed excessive bad habits in their logical thinking has great potential for stimulating productive lifelong learning. That is why Dr. Hughes is now internationally known for his vision on education of critical thinking, while Consultant and Clinical Director of Emergency Medicine in Barnsley.
As inscrições (3ª fase) para o VI In4Med irão abrir a 23 de Janeiro, às 21h00. De modo a que te possas registar e a que sejas rápido a fazê-lo, deverás ler e seguir estas instruções.
Primeiro passo: no dia 23 de Janeiro, às 21h00, será disponibilizado um formulário que deverás preencher rapidamente para assegurares uma vaga no congresso. Poderás encontrar este formulário tanto no nosso site (http://nemaac.net/in4med/) como no nosso facebook (https://www.facebook.com/in4med.nemaac/).
Segundo passo: de modo a validares a tua inscrição, deverás pagar o preço do bilhete e enviar um comprovativo de pagamento para o seguinte e-mail: firstname.lastname@example.org. Para que possas proceder ao pagamento, irás receber um e-mail com os respectivos dados. Se te tiveres inscrito também para o programa social, deverás também proceder ao pagamento do valor correspondente. Poderás fazê-lo até dia 24 de Janeiro.
Depois de enviares o comprovativo de pagamento, irás receber um e-mail que confirmará a tua inscrição.
Terceiro Passo (Seriação para a escolha de Workshops): numa data ainda a anunciar, irás receber um formulário que deverás preencher rapidamente se queres ser colocado nas tuas primeiras escolhas de workshops. É um formulário que te irá seriar de acordo com o tempo e em que terás apenas que colocar alguns dos teus dados pessoais.
Quarto passo (Selecção de Workshops): depois de teres completado o terceiro passo, irás receber um terceiro formulário onde poderás ordenar os workshops de acordo com a tua preferência. Terás algum tempo para o fazeres, pelo que não há motivos para te apressares.
Se tiveres dúvidas podes contactar-nos através do seguinte e-mail: email@example.com.
Holder of an unique curriculum, Dr. Paolo was the director of the Department of Pediatric Surgery at D. Estefânia’s Hospital, member of the National Woman, Children and Adolescent Health Committee (2011-2014) and Past-President of the Portuguese Society of Pediatric Surgery (2008-2012).
He is currently the president of the Paediatric Surgery College of the Portuguese Medical Association.
He was distinguished by numerous international awards such as the Pfitzer Prize for Young Investigators in 1998, the Maria Amélia de Mello Prize for Health Sciences in 2004, the 2009 START Grand Prize and the International Pediatric Endoscopic Group Award in 2010.
He is the author of numerous articles published in major Journals related to medicine and investigation, and he is also an Ad hoc revisor for several journals including the Journal of Pediatric Surgery.
Jorge Correia Pinto is a leading researcher of the ICVS / 3B of MU and the coordinator of the Research Area in Surgical Science.
He is also the Chairman of the Board of the General Assembly of the Portuguese Society of Pediatric Surgery.
Correia Pinto is the Karl Storz international consultant for the design of new instruments and coordinator of programs related to the training of surgeons in minimally invasive surgery.
His work in areas of fetal and neonatal lung development are noteworthy, especially his research on congenital diaphragm hernia, pulmonary hypoplasia and hypertension, and possible genetically modulated therapy
Jorge Correia Pinto is a remarkable surgeon and pioneer, in Portugal and worldwide, in minimally invasive surgery in neonates.
Dr. Wildhaber is very enthusiastic and took postgraduate courses at the Cantonal Hospitals and Universities in Zug, Lucuna, Zurich and South Africa. She has been involved in an investigation project on short gut syndrome and parenteral nutrition.
She pursued paediatric surgery and now she is a well-known specialist on hepatic transplant and hepatobiliary surgery in paediatrics.
In 2011, she started working in Lion Hospital at paediatics hepatic surgery section and is, at the moment, chief at the University Geneva Hospital and teacher at Geneva Hospital.
Recently, she and her team were involved on the separation of the eight-day-old conjoined twin sisters fused at the liver and chest, in Switzerland. This intervention was incredibly successful despite the circumstances.
He’s an Assistant Researcher at the “Centre for Neuroscience and Cell Biology” of Coimbra, since 2013. He has been involved in various research projects, including “Autism Speaks Research”, of the Autism Speaks Foundation, several from the Brain & Behaviour Research Foundation and many others at FST. He was awarded with the title of “NARSAD Young Investigator” and due to his participation, the “Marie Curie Career Integration Grant” was awarded to him, in order to guarantee bigger financial longevity to the investigations he has proposed himself to.
His work aims to better understand synaptic computation and how these gives rise to behavioural programs. To do so, he employs knowledge from different areas, such as molecular genetics, optogenetics and electrophysiology.
Dr. Rodrigo Cunha is an prolific investigator, who has a wild fascination for adenosine and its role in neuromodulation in Neurodegenerative diseases. In 2004, his team was graced with the Belard Montero Award, due to their work on the role of caffeine in Parkinson’s and Alzheimer’s Diseases.
Today, Dr. Rodrigo Cunha is a lead investigator at the Centre for Neurosciences and Cell Biology, of the University of Coimbra (CNC) and participates in the Steering Committee of the European Neuroscience Campus and in the National representative of the Network of European Neuroscience Institutes. In addition, he is leading the group responsible for purines at the CNC, which is focused on the neuroprotective effect of caffeine and purinergic modulation. He is incredibly enthusiastic and has published over 180 articles, with an impact factor of 47. His work on modelling the progression of Alzheimer’s Disease is revolutionary worldwide.
Holder of a Master in human movement science and a PhD on Neurosciences from the University of Grenoble (France), Dr. Mignardot is currently working in the Laboratory of Prof. Grégoire Courtine at the Swiss Federal Institute of Technology (EPFL, École Polytechnique Féderale de Lausane), and at the university hospital of Lausanne (CHUV) in Switzerland.
The ultimate goal of his research aims to restore voluntary control of motor function in people with neuromotor disorders through innovative rehabilitation paradigms which involve invasive electrical stimulation of the spinal cord and robotic technologies.
Dr. Mignardot is involved in the development of neuroprosthetics tools for neuromodulation of the central nervous system and the design of algorithms to control new generation of body-weight support systems by using machine learning.
Currently, he applies these concepts in animal studies and clinical trials such as the ‘STIMO’ project which aims to improve gait capacity of people with spinal cord injury through a closed-loop control of the spinal cord stimulation during long-term neurorehabilitation.
Besides being a researcher in the area of Health Biotechnology and Bioengineering, he is also the coordinator of important projects regarding those areas such as FOLSMART – Folate-Target Nanodevices to Activated Macrophages for Rheumatoid Arthritis and INFACT – Functional materials for fast diagnosis of wound infection. The FOLSMART project is an international consortium and represents an innovative approach of nanotechnology for the diagnosis and treatment of chronic inflammatory diseases such as rheumatoid arthritis. This technology is an alternative to currently available treatments, including TNF-alpha inhibitors drugs, which are usually associated with severe side effects.